Brazil is the tenth largest market in the world for pharmaceutical products, with sales of over U$ 12,5 billion in 2008 as per IMS, Brazil. This makes Brazil one of the key markets for Zydus Cadila and a hub for its operations in Latin America.

Zydus Healthcare Brasil Ltda. registered at Sao Paulo is subsidiary of Cadila Healthcare Ltd, India.  Currently the company supplies the market with generic and similar drugs of high-quality, all approved by ANVISA.